S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q1 2021

Baker Bros Advisors

Periodo: Q1 2021 Β· Depositato: 2021-05-17
Vedi su SEC EDGAR β†—
AUM
$23.07B
Valore totale del portafoglio
Posizioni
126
Titoli dichiarati
Prima Posizione
SGEN
28.5% $6.56B
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-05-17) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SGENSeagen Inc.$6.56B28.46%β€”β€”
28.5%
ONCBeiGene, Ltd.$4.06B17.61%$348.08$297.65-14.5%
17.6%
INCYIncyte Corporation$2.60B11.28%$81.27$116.86+43.8%
11.3%
KODKodiak Sciences Inc.$1.57B6.82%$113.39$38.54-66.0%
6.8%
ACADACADIA Pharmaceuticals Inc.$1.08B4.69%$25.80$25.97+0.7%
4.7%
ALXNAlexion Pharmaceuticals, Inc.$610.6M2.65%β€”β€”
2.6%
NVTAQInvitae Corporation$601.8M2.61%β€”β€”
2.6%
BMRNBioMarin Pharmaceutical Inc.$573.1M2.48%$75.51$58.99-21.9%
2.5%
ASNDAscendis Pharma A/S$456.3M1.98%$128.88$274.50+113.0%
2.0%
PRLDPrelude Therapeutics Incorporated$438.7M1.90%$43.33$4.91-88.7%
1.9%
ABCLAbCellera Biologics Inc.$354.9M1.54%$33.96$8.11-76.1%
1.5%
ARGXargenx SE$308.3M1.34%$275.39$939.68+241.2%
1.3%
IGMSIGM Biosciences, Inc.$242.0M1.05%β€”β€”
1.1%
MRTXMirati Therapeutics, Inc.$241.5M1.05%β€”β€”
1.1%
MDGLMadrigal Pharmaceuticals, Inc.$175.4M0.76%$116.97$528.10+351.5%
0.8%
AMRNXXXXAmarin Corporation plc$164.3M0.71%β€”β€”
0.7%
GBTGlobal Blood Therapeutics, Inc.$131.1M0.57%β€”β€”
0.6%
BCRXBioCryst Pharmaceuticals, Inc.$129.3M0.56%$10.17$9.84-3.2%
0.6%
IMCRImmunocore Holdings plc$107.3M0.47%$42.57$32.50-23.7%
0.5%
PACBPacific Biosciences of California, Inc.$106.7M0.46%$33.31$1.68-95.0%
0.5%
TILInstil Bio, Inc.$97.7M0.42%$501.60$7.73-98.5%
0.4%
TLISTalis Biomedical Corporation$97.3M0.42%β€”β€”
0.4%
HRTXHeron Therapeutics, Inc.$97.2M0.42%$16.21$0.44-97.3%
0.4%
CERSCerus Corporation$82.4M0.36%$6.01$3.16-47.4%
0.4%
ALLKAllakos Inc.$80.7M0.35%β€”β€”
0.3%
DBVTDBV Technologies S.A.$77.9M0.34%$10.66$15.82+48.4%
0.3%
NRIXNurix Therapeutics, Inc.$76.3M0.33%$31.09$23.97-22.9%
0.3%
KYMRKymera Therapeutics, Inc.$76.1M0.33%$38.86$113.51+192.1%
0.3%
RYTMRhythm Pharmaceuticals, Inc.$74.0M0.32%$21.27$114.17+436.8%
0.3%
INSMInsmed Incorporated$73.4M0.32%$34.06$111.60+227.7%
0.3%

AttivitΓ  Trimestre su Trimestre

Q1 2021 vs. Q4 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
IMCRImmunocore Holdings plc$107.3M-23.7%
TILInstil Bio, Inc.$97.7M-98.5%
TLISTalis Biomedical Corporation$97.3M
DSGNDesign Therapeutics, Inc.$43.0M
ACHLAchilles Therapeutics plc$42.9M
OTICOtonomy, Inc.$18.4M
EWTXEdgewise Therapeutics, Inc.$16.3M
Sarepta Therapeutics, Inc.$12.0M

Posizioni Chiuse (8)

TickerEmittenteNozionale
ADPTAdaptive Biotechnologies Corporation$22.4M
GWPHGW Pharmaceuticals plc$13.0M
FPRXFive Prime Therapeutics, Inc.$11.4M
VXRTVaxart, Inc.$8.0M
NTLAIntellia Therapeutics, Inc.$6.1M
GOSSGossamer Bio, Inc.$4.7M
DRNADicerna Pharmaceuticals, Inc.$2.3M
OVIDOvid Therapeutics Inc.$2.2M

Aumentate (8)

TickerEmittenteNozionaleVar. Azioni
EVFMEvofem Biosciences, Inc.$3.7M+555.6%
GBTGlobal Blood Therapeutics, Inc.$91.3M+249.6%
NGMNGM Biopharmaceuticals, Inc.$5.3M+173.7%
IMTXImmatics N.V.$25.3M+121.2%
ORTXOrchard Therapeutics plc$3.9M+120.9%
APLSApellis Pharmaceuticals, Inc.$20.6M+86.7%
VSTMXXXXVerastem, Inc.$20.4M+67.8%
TCRRTCR2 Therapeutics Inc.$0.5M+59.1%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
FREQFrequency Therapeutics, Inc.$-29.7M-93.5%
IFRXInflarx N.V.$-3.8M-83.9%
IDRAIdera Pharmaceuticals, Inc.$-14.3M-55.6%
ALXNAlexion Pharmaceuticals, Inc.$-758.2M-54.4%
SGMOSangamo Therapeutics, Inc.$-8.0M-50.0%
AUTLAutolus Therapeutics plc$-4.3M-41.0%
GMDAQGamida Cell Ltd.$-4.6M-33.0%
HRMYHarmony Biosciences Holdings, Inc.$-2.4M-31.3%
← Torna agli Hedge Fund